3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase NA
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
17
Other neoplasm
1
Other
1
NET
1
Head & Neck
1
Genitourinary
1
Endocrine
1
Conditions
Neuroendocrine Tumors
50
Pancreatic Neoplasms
6
Gastrointestinal Neoplasms
6
Stomach Neoplasms
5
Carcinoma, Hepatocellular
5
Colorectal Neoplasms
4
Rectal Neuroendocrine Tumor
3
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Liver Neoplasms
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Thyroid Neoplasms
2
Rectal Neoplasms
2
Neoplasms
2
Gastrointestinal Stromal Tumors
2
Gastro-enteropancreatic neuroendocrine tumor
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Carcinoma
2
Carcinoid Tumor
2
Biliary Tract Neoplasms
2
Appendiceal Neoplasms
2
Anus Neoplasms
2
Visceral Pain
1
Serotonin Syndrome
1
Recurrence
1
Rectal Neuroendocrine Tumors
1
Pheochromocytoma
1
Patients With Gastroenteropancreatic Neuroendocrine Tumors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Digestive System Diseases
×
NET
×
Clear all
NCT07377487
2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA
Recruiting
51 enrolled